NCT01267955 2026-03-18Vismodegib in Treating Patients With Advanced ChondrosarcomasNational Cancer Institute (NCI)Phase 2 Active not recruiting45 enrolled 10 charts
NCT02048371 2023-11-07SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma SubtypesSarcoma Alliance for Research through CollaborationPhase 2 Completed131 enrolled 22 charts